ASEX
ILYDA
Market cap83mUSD
Nov 12, Last price
5.26EUR
Name
Ilyda SA
Chart & performance
P/E
16.76
P/S
8.25
EPS
0.31
Div yield, %
0.38%
Shrs. gr., 5y
2.72%
Rev. gr., 5y
18.06%
Revenues
9m
+26.41%
Net income
4m
+15.93%
CFO
9m
+200.56%
Dividend
Jun 25, 20260.09 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ilyda S.A. is a Greek software development firm specializing in a broad spectrum of business solutions. Its offerings include general enterprise resource planning (ERP) platforms such as MegaTron ERP and Kinitron Smart ERP. The company also tailors specialized systems for specific industries, providing the Dioscourides Smart, XPress, and Retail System ERPs for pharmacies, MegaTron Pharma ERP for drugstores, and the LIS Bio-Diagnosis system for microbiological laboratories. Furthermore, Ilyda develops targeted applications for public and utility sectors, including MegaTron DEVA for water supply and sewerage companies, PSIS Financial Management for public sector entities, PSIS Payroll & Personnel Management for legal organizations, and SIS Secretariats for educational institutions. Beyond software creation, the company offers extensive support services, encompassing telephone, remote, on-site, and feedback-based assistance, as well as project design and implementation, and comprehensive software training. Founded in 1992, Ilyda S.A. is headquartered in Athens, Greece.
Key people
Georgios Tsiatouras
Non-Executive Vice Chairman of the Board · since 2010
Georgios Ntouras
Chief Financial Officer · since 2006
Vasileios Anyfantakis
Executive Chairman of the Board, Managing Director · since 2008
Athanasios Anastasiadis
Non-Executive Independent Director · since 2008
Filippos Koutsikos
Non-Executive Independent Director · since 2013
Apostolos Papadakis
Non-Executive Independent Director · since 2010
Headquarters & legal address
ADRIANEIOU 29
ATHENS, I 11525
GR
ATHENS, I 11525
GR
Trading name
ΙΛΥΔΑ ΠΛΗΡΟΦΟΡΙΚΗ Α.Ε.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||